Partner with Helomnix
We collaborate with pharmaceutical companies, research institutions, and clinical teams on structured analytical engagements designed to support translational development programs.
Helomnix operates as reproducible disease-state infrastructure — aligning scientific objectives, data governance, and program strategy within defined analytical scopes.
How We Work
Every collaboration begins with a clearly defined scientific objective and structured analytical scope. Helomnix integrates within existing translational workflows — aligning with biomarker, clinical development, and portfolio teams — and operates under defined documentation and version-control standards.
Engagements are structured around:
- Pre-specified analytical milestones
- Defined data boundaries and access controls
- Version-locked modeling artifacts
- Deterministic cohort projection workflows
- Structured reporting outputs for cross-functional evaluation
Our role is to provide reproducible biological structure that strengthens program-level decision-making.
Engagement Models
Three structured entry points support different stages of development maturity.
Scoping Engagement
A scoped analytical engagement designed to evaluate fit and define translational hypotheses within a defined dataset.
- Defined analytical scope and milestones
- Structured cohort projection and state modeling
- Documented biological state outputs
- Cross-functional interpretability framework
Co-Development Program
Joint biomarker and stratification development programs aligned to shared scientific objectives and clearly defined IP and data governance structures.
- Shared scientific milestones
- Joint hypothesis refinement
- Structured documentation of modeling artifacts
- Defined data ownership and governance terms
Programmatic Collaboration
Long-term structured partnerships supporting multi-program precision development strategies across disease areas.
- Multi-dataset harmonization
- Cross-indication reference map expansion
- Ongoing translational strategy support
- Dedicated scientific engagement model
Structured Pilot Deliverables
Pilot engagements produce structured analytical assets designed for translational evaluation.
Cohort State Mapping Package
Projection of your cohort onto a version-locked reference map with documented state distribution summaries and comparability metrics.
Functional State Characterization Dossier
Defined biological state descriptions, molecular context summaries, and pathway-level organization specific to your dataset.
Target & Biomarker Context Assessment
State-resolved context analysis to inform prioritization and translational hypothesis refinement.
Translational Strategy Brief
Structured interpretation framework outlining stratification logic, validation considerations, and next-step analytical pathways.
Data Governance & IP Alignment
Collaborations are structured around clearly defined data ownership, access control, and intellectual property boundaries.
Helomnix can operate within partner-secured environments when required. Modeling artifacts and structured outputs are version-tracked and documented to ensure reproducibility and program continuity.
Engagement terms are aligned prior to analytical execution.
Engagements are structured to ensure continuity, comparability, and methodological integrity across development phases.
Collaboration Control Framework
Defined Scope
Data Governance Agreement
Version-Locked Modeling
Structured Deliverables
Joint Interpretation
Clinical Access & Academic Research Infrastructure
Institutional Partners
Helomnix is built on collaborative relationships with leading French research institutions in hematology and molecular biology.
CHU de Montpellier
Strategic biobank partnership providing longitudinal multi-omics biobanking in Multiple Myeloma, DLBCL, and AML. Unique access to in-vitro B-to-plasma cell differentiation models and clinical sample generation for translational validation.
IGH-CNRS / CNRS UMR 9002
Research collaboration on epigenome modifications and genomic instability in normal and malignant B cells. Multi-omics integration for mechanistic target discovery and translational research.
Université de Montpellier
Academic partnership supporting translational hematology and computational biology research. Co-supervised programs and shared scientific governance reinforce continuity across institutional and clinical environments.
Discuss a Structured Collaboration
If you are advancing a translational program, refining a stratification strategy, or evaluating a new target hypothesis, we welcome the discussion.
Initiate a Scientific Discussion